Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biofluid Biopsies 2016

Biofluid Biopsies 2016



Keynote Speakers


Pravin D Potdar
Head, Jaslok Hospital & Research Centre


Chamindie Punyadeera
Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology


David Smith
Professor, Mayo Clinic

Overview

SELECTBIO is delighted to announce its highly focused International Conference Biofluid Biopsies which is scheduled to be held on May 27, 2016 in Sheraton Grand Bangalore Hotel at Brigade Gateway, Bengaluru, India.

This single day event, focuses primarily on blood-based molecular biomarkers such as Circulating Tumor DNA (ctDNA) for developing biological fluid-based biopsies as well as Circulating Tumor Cells (CTCs) and Protein-based Circulating Biomarkers. This event is beneficial for the Scientists who are working or planning to work in the area of extracellular nucleic acids, extracellular vesicles, circulating cell free DNA, microRNA, Liquid biopsies etc. 

This conference will provide scientists and researchers with most up-to-date information & emerging trends in the area of Biofluid Biopsies. Open discussions and break-out sessions on key thematic areas are sure to energize the participants in defining the Circulating Biomarkers Landscape, especially in the Indian context.

This event is co-located with our International Conferences “Advanced Diagnostics 2016”, “Biomarkers India 2016”, Microfluidics, Liquid Handling and Lab-on-a-Chip and “Metabolomics India 2016”. Running alongside the conference will be an Exhibition covering the latest technological advances within these fields. Registered delegates will have unrestricted access to all the co-located meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.

We look forward to welcoming you at the Biofluid Biopsies Conference and Exhibition and hope that the day will be both informative and enjoyable.


Agenda Topics

  • Analysis of Somatic Mutations in ctDNA and CTCs
  • Circulating RNAs as a Potential Biomarker Class
  • Circulating Tumor Cells (CTCs) as Prognostic Biomarkers
  • Digital PCR (dPCR) Applications for Circulating Biomarker Interrogation
  • Emerging Technology Platforms for Developing Biofluid-based Biopsies
  • Extracellular Nucleic Acids based Technologies
    • Cell-Free DNA (cfDNA)
    • Extracellular RNA (exRNA)
  • Extracellular Vesicles (EVs) for Development of Biofluid-based Biopsies

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager
mjsingh@selectbio.com
7696225050

Distinguished Faculty

Clark Chen, Co-Director, University of California-San Diego
Shibichakravarthy Kannan, Founder & CEO, Theranosis Life Sciences Pvt Ltd
Winston Patrick Kuo, President, Predicine Holdings Ltd
Suraj Shankar, Research Scholar, PES Institute of Technology
Ujjwala Warawdekar, Scientific Officer E, Advanced Centre for Treatment Research and Education in Cancer


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks